Efficacy and Safety of Focused Shockwave Therapy Plus Tadalafil vs Tadalafil Alone in Patient With Erectile Dysfunction

Last updated: May 2, 2023
Sponsor: Saint Petersburg State University, Russia
Overall Status: Active - Recruiting

Phase

N/A

Condition

Impotence

Infertility

Erectile Dysfunction

Treatment

PDE5 inhibitor (tadalafil) and BTL-6000 fSWT

PDE5 inhibitor (tadalafil)

Clinical Study ID

NCT05823506
ESWT_tadalafil_in_ED
  • Ages 20-45
  • Male

Study Summary

The goal of this trial is that using tadalafil plus low-intensity extracorporeal shockwave therapy (li-ESWT) is more effective than using tadalafil alone in improving erection rigidity and sexual function. The efficacy of the combination of li-ESWT and tadalafil has been confirmed by a number of studies, including in patients after radical prostatectomy. However, this method is still not a "first-line" method in young primary patients and its benefits in combination with drugs for these patients are not obvious.

The investigators assume that the combination of tadalafil plus low-intensity extracorporeal shockwave therapy (li-ESWT) will improve the subjective state of patients assessed by points of validated questionnaires and Number of successful intercourse per week.

Eligibility Criteria

Inclusion

Inclusion Criteria:• Age 20 to 45;

  • Married or have had a permanent sex partner for at least 3 months;
  • IIEF-5 questionnaire scores below 20

Exclusion

Exclusion Criteria:

  • History of previous use of PDE-5 inhibitors or fSWT;
  • Patients with diabetes mellitus;
  • Patients after the radical prostatectomy or major pelvic surgery;
  • Patients with a confirmed neurological disease that may have caused the ED (MultipleSclerosis, Parkinson's Disease, spinal cord injury);
  • Patients with contraindications to the use of PDE-5 inhibitors and/or fSWT;

Study Design

Total Participants: 36
Treatment Group(s): 2
Primary Treatment: PDE5 inhibitor (tadalafil) and BTL-6000 fSWT
Phase:
Study Start date:
February 01, 2023
Estimated Completion Date:
February 01, 2024

Study Description

The aim of the study is to test the hypothesis that using tadalafil plus shockwave in primary patient with ED treatment in more effective in improving erection rigidity and sexual function, then using tadalafil alone.

Connect with a study center

  • SBPSU

    Saint Petersburg,
    Russian Federation

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.